Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.

doi:10.1002/jmv.29881

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.

Journal of medical virology - 1 Sept 2024

Arbyn Marc, Cuschieri Kate, Bonde Jesper, Schuurman Rob, Cocuzza Clementina, Broeck Davy Vanden, Zhao Fang-Hui, Rezhake Remila, Gultekin Murat, de Sanjosé Silvia, Canfell Karen, Hawkes David, Saville Marion, Hillemanns Peter, Dillner Joakim, Berkhof Johannes, Prétet Jean-Luc, Gheit Tarik, Clifford Gary, Basu Partha, Almonte Maribel, Wentzensen Nicolas, Poljak Mario

Abstract excerpt

While HC2 and GP5+/6+ PCR-EIA were pivotal in test validation of new HPV assays, they represent the first generation of comparator tests based upon technologies that are not in widespread use anymore. In the current guideline, criteria for second-generation comparator tests are presented that include more detailed resolution of HPV genotypes. Second-generation comparator tests should preferentially target only...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Human Papillomavirus DNA Tests

Share to Molecular Diagnostic Techniques

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Sensitivity and Specificity

Share to Uterine Cervical Neoplasms

Source

Open in PubMed

Identifiers

PMID: 39221498
DOI: 10.1002/jmv.29881

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.PMID 39221498Read ↗

Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.Semantic proximity Read ↗

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.Semantic proximity Read ↗

Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.Semantic proximity Read ↗

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.Semantic proximity Read ↗

A review of the clinical performance of the Aptima HPV assay.Semantic proximity Read ↗

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework.Semantic proximity Read ↗

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.Semantic proximity Read ↗

CHAPTER 7 Methods for detection of HPV infection and its clinical utilitySemantic proximity Read ↗

Chapter 12: Human Papillomavirus TechnologiesSemantic proximity Read ↗

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.Semantic proximity Read ↗

Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.Semantic proximity Read ↗

Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.